California State Teachers Retirement System Brainstorm Cell Therapeutics Inc. Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.01 - $4.01 $135,040 - $179,904	-44,864 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$3.46 - $7.88 $5,677 - $12,931	1,641 Added 3.8%	44,864 $172,000
Q3 2020 Nov 17, 2020	BUY	$11.19 - $16.92 $33,704 - $50,963	3,012 Added 7.49%	43,223 $731,000
Q2 2020 Aug 17, 2020	BUY	$4.42 - $12.66 $177,732 - $509,071	40,211 New	40,211 $451,000

Others Institutions Holding BCLI

# of Institutions

Shares Held

10.5M

Call Options Held

160K

Put Options Held

30.5K

Armistice Capital, LLC New York, NY

6.9M
Shares

$13.1 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

1.51M
Shares

$2.87 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

683K
Shares

$1.3 Million
0.0% of portfolio
Black Rock Inc. New York, NY

386K
Shares

$734,186
0.0% of portfolio
Liberty Wealth Management LLC Oakland, CA

340K
Shares

$646,285
0.01% of portfolio

View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $69.3M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

More about BCLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account